Welcome!

News Feed Item

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022


EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

Summary

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health. As obesity is a complex condition associated with a wide range of lifestyle, genetic, social, cultural, and environmental factors, its prevalence may vary across countries, depending on the variations in these contributing factors.

GlobalData's epidemiological analysis forecasts that prevalent cases of overweight in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase from 250.05 million in 2012 to 271.86 million cases in 2022 at an annual growth rate (AGR) of 0.86%. Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in 2012 were in men. GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR of 2.75%. Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012 were in women.

According to GlobalData's forecast, the prevalent cases of both overweight and obesity will increase dramatically over the next decade, with the number of obese adults increasing by an alarming 27.50%. Overweight and obesity have reached pandemic proportions; however, GlobalData epidemiologists believe that with the alarming increase in the prevalence of both overweight and obesity, the morbidity and mortality associated with the disease will continue to increase dramatically as well.

Scope

- The Overweight and Obesity EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of overweight and obesity in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada). It includes a 10-year epidemiology forecast of the prevalent cases of overweight, obesity, obesity class I, obesity class II, and obesity class III segmented by sex and age. In addition, the report includes a 10-year forecast of the prevalent cases of obesity-associated comorbidities, including diagnosed diabetes, diagnosed hypertension, and dyslipidemia, among adults with overweight/obesity in some of these markets.
- The overweight and obesity epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global overweight and obesity market.
- Quantify patient populations in the global overweight and obesity market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered.
- Identify the number of obesity class I, obesity class II, and obesity class III prevalent cases.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Epidemiology 12

3.1 Disease Overview 12
3.2 Risk Factors and Comorbidities 13
3.2.1 Family history is a strong predictor of obesity 13
3.2.2 Physical inactivity is an independent predictor of obesity 14
3.2.3 Excessive caloric intake doubles the risk for obesity 15
3.2.4 Hypertension is as high as 42% in obese adults 16
3.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients 17
3.3 Global Trends 19
3.3.1 US 20
3.3.2 5EU 22
3.3.3 Japan 28
3.3.4 Brazil 29
3.3.5 Canada 31
3.4 Forecast Methodology 32
3.4.1 Sources Used 39
3.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by Class, and Comorbidities 46
3.4.3 Sources Not Used 63
3.5 Epidemiology Forecast of Overweight (2012–2022) 63
3.5.1 Prevalent Cases of Overweight 63
3.5.2 Age-Specific Prevalent Cases of Overweight 65
3.5.3 Sex-Specific Prevalent Cases of Overweight 67
3.5.4 Age-Standardized Prevalence of Overweight 70
3.6 Epidemiology Forecast of Obesity (2012–2022) 71
3.6.1 Prevalent Cases of Obesity 71
3.6.2 Age-Specific Prevalent Cases of Obesity 73

3.6.3 Sex-Specific Prevalent Cases of Obesity 75
3.6.4 Age-Standardized Prevalence of Obesity 76
3.7 Epidemiology Forecast of Obesity Class I (2012–2022) 77
3.7.1 Prevalent Cases of Obesity Class I 77
3.7.2 Age-Specific Prevalent Cases of Obesity Class I 79
3.7.3 Sex-Specific Prevalent Cases of Obesity Class I 81
3.7.4 Age-Standardized Prevalence of Obesity Class I 83
3.8 Epidemiology Forecast of Obesity Class II (2012–2022) 85
3.8.1 Prevalent Cases of Obesity Class II 85
3.8.2 Age-Specific Prevalent Cases of Obesity Class II 87
3.8.3 Sex-Specific Prevalent Cases of Obesity Class II 89
3.8.4 Age-Standardized Prevalence of Obesity Class II 91
3.9 Epidemiology Forecast of Obesity Class III (2012–2022) 93
3.9.1 Prevalent Cases of Obesity Class III 93
3.9.2 Age-Specific Prevalent Cases of Obesity Class III 95
3.9.3 Sex-Specific Prevalent Cases of Obesity Class III 97
3.9.4 Age-Standardized Prevalence of Obesity Class III 99
3.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and 2022) 101
3.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity 101
3.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity 104
3.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity 106
3.11 Discussion 109
3.11.1 Conclusions on Epidemiological Trends 109
3.11.2 Limitations of the Analysis 110

3.11.3 Strengths of the Analysis 111
4 Appendix 112
4.1 Bibliography 112
4.2 About the Authors 118
4.2.1 Epidemiologists 118
4.2.2 Reviewers 118
4.2.3 Global Director of Epidemiology and Health Policy 119
4.2.4 Global Head of Healthcare 120
4.3 About GlobalData 121
4.4 About EpiCast 121
4.5 Disclaimer 121

1.1 List of Tables

Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI 12
Table 2: Risk Factors and Comorbidities of Obesity 13
Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ?20 Years, 2008 20
Table 4: JASSO and WHO Classifications of Obesity 28
Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight 33
Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity 34
Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I, Class II, and Class III 36
Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in Overweight/Obese 38
Table 9: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 64
Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012 66
Table 11: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 68

Table 12: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 72
Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 74
Table 14: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), Row (%), 2012 75
Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 78
Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 80
Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 82
Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 86

Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 88
Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 90
Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 94
Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 96
Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 98
Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 102
Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 105
Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 107

1.2 List of Figures

Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–2010 21
Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–2010 21
Figure 3: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Men, 1997–2006 23
Figure 4: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Women, 1997–2006 23
Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Men, 1993–2011 27
Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Women, 1993–2011 27
Figure 9: Japan, Obesity Prevalence (%), Ages ?20 Years, By Sex, 1976–2006 29
Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Men, 1975–2003 30
Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Women, 1975–2003 30
Figure 12: Canada, Obesity Prevalence (%), Ages ?18 Years, Both Sexes, 1978–2008 32
Figure 13: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 65
Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 67
Figure 15: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, by Sex, N (Millions), 2012 69
Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 71
Figure 17: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 73

Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 74
Figure 19: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), 2012 76
Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 77
Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 79
Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 81
Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, by Sex, N (Millions), 2012 83
Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ?18 Years, by Sex, 2012 84
Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 87
Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 89
Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, by Sex, N (Millions), 2012 91
Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ?18 Years, By Sex, 2012 92
Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 95
Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 97
Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), 2012 99
Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 100
Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 103
Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 106
Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 108

Read the full report:
EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_overweight_obesity_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices t...
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to clos...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
The past few years have brought a sea change in the way applications are architected, developed, and consumed—increasing both the complexity of testing and the business impact of software failures. How can software testing professionals keep pace with modern application delivery, given the trends that impact both architectures (cloud, microservices, and APIs) and processes (DevOps, agile, and continuous delivery)? This is where continuous testing comes in. D
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...